News Agency
The Times

CARsgen 2022 Interim Results: Innovative CAR T-cell Technologies and Robust Pipeline

  • Written by PR Newswire
CARsgen 2022 Interim Results: Innovative CAR T-cell Technologies and Robust Pipeline

SHANGHAI, Aug. 24, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, has announced the 2022 Interim Results.

Business Highlights

  • CT053: completed enrollment for pivotal Phase II trial in China,...

Read more: CARsgen 2022 Interim Results: Innovative CAR T-cell Technologies and Robust Pipeline

Executive Recruitment And The Value Of Executive Recruitment Agencies In Modern Hiring

Finding the right leadership talent is one of the most important decisions an organisation can make. Strong leaders influence company culture, business performance, strategic direction, and long-term growth. As competition for experienced executives continues to increase, executive recruitment has become a... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion